JPRN-UMIN000000766已完成1 期
A phase I study to evaluate the effect and recommended dose of 5-FU(rapid infusion and drip infusion)/l-LV therapy for advanced and/or recurrent colon cancer (OGSG 0406) - OGSG 0406
OGSG0 个研究点目标入组 24 人开始时间: 2007年7月13日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.with severe bone marrow suppression 2.with a severe infection 3.with severe cardiac disease 4.with some other severe diseases 5.under a poor general condition 6.under diarrhea which continues more than three days 7.with double cancers which were treated within recent 5 years except carcinoma in situ. 8.with familial polyposis or hereditary disease 9.under pregnancy or nursing 10.with a history of allergic response to Levoholinate or fluorouracil 11.re-registration to this study 12.doctors' decision not to register
研究者
相似试验
已完成
不适用
A randomised comparative crossover study to assess the affect on circuit life of varying pre-dilution volumes associated with Continuous Veno-Venous Haemofiltration (CVVH) and Continuous Veno-Venous Haemodiafiltration (CVVHDF).ACTRN12606000045516Department of Health Western Australia30
进行中（未招募）
1 期
Efficacy and safety of niraparib in combination with cabozantinib in patients with advanced urothelial cancer.EUCTR2017-004367-12-ESFundación CRIS de investigación para vencer el cáncer71
招募中
2 期
A Phase I-II Clinical Study of Nimotuzumab (TheraCIM h-R3) in Combination with External Radiotherapy in Stage IIB, III and IV Non-Small Cell Lung Cancer (NSCLC)ACTRN12610000571077YM BioSciences Inc.128
进行中（未招募）
1 期
A Phase I/II Study to Investigate the Efficacy and Safety of AER 002 in Cystic Fibrosis Given at 3 mg, 10 mg, and 30 mg Doses in Single then Multiple Ascending Doses and to Determine Efficacy of the Highest Tolerable Dose in a 4-Week Proof of Concept StudyCystic FibrosisEUCTR2005-000313-35-GBAerovance Inc106
招募中
不适用
Preliminary study on evaluating the effectiveness of outpatient Morita therapy for agoraphobiaagoraphobiaJPRN-UMIN000042870Department of Neuropsychiatry, Keio University School of Medicine10